Top

Quality of Life Research

Published in:

Open Access 01-01-2018

Everyday life following hematopoietic stem cell transplantation: decline in physical symptoms within the first month and change-related predictors

Authors: Aleksandra Kroemeke, Małgorzata Sobczyk-Kruszelnicka, Zuzanna Kwissa-Gajewska

Published in: Quality of Life Research | Issue 1/2018

Abstract

Purpose

Lower quality of life, especially in the physical domain (Physical-QOL), is common in patients after hematopoietic stem cell transplantation (HSCT). However, few studies explore changes in the Physical-QOL, i.e., physical symptoms, in everyday life of patients following HSCT. The present study addresses this gap by examining patient daily physical symptoms and their predictors in terms of demographic and clinical characteristics.

Methods

Physical symptoms were reported by 188 patients (56.9% men; aged 47.6 ± 13.4 years) for 28 consecutive days after post-HSCT hospital discharge. Multilevel modeling was used to investigate fixed and random effects for physical symptom changes over time.

Results

The results indicated that the initial level of physical symptoms (immediately after hospital discharge) systematically decreased over 28 days. Treatment toxicity (WHO scale; β = 0.09, p < .01) and baseline depressive symptoms (CES-D scale; β = 0.06, p < .01) were associated with the initial level of physical symptoms. Patients with more depressive symptoms before HSCT and with more adverse treatment effects presented with more physical symptoms immediately after hospital discharge. The type of transplant, diagnosis, and conditioning regimen differentiated the course of physical symptoms. Patients with leukemias and other myeloid neoplasms (β = 0.05, p < .01), after allogeneic HSCT (β = −0.06, p < .01), and with non-myeloablative conditioning (β = −0.09, p < .01) showed a significant lower decrease in symptoms over time. Patients with multiple myeloma presented with the most rapid improvement (β = −.03, p < .05).

Conclusions

The findings suggest a heterogeneous and rather positive response to HSCT. Treatment-related conditions occurred to be a significant predictor of the intensity of change in physical functioning after HSCT.

Xu, Y., Sun, Y., Shen, H., Ding, L., Yang, Z., Qiu, H., & Wu, D. (2015). Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations. American Journal of Hematology, 90(11), 992–997. doi:10.1002/ajh.24135.CrossRefPubMed

Yanada, M., Matsuo, K., Suzuki, T., & Naoe, T. (2006). Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia. Cancer, 106(12), 2657–2663. doi:10.1002/cncr.21932.CrossRefPubMed

Bennett, A. V., Reeve, B. B., Basch, E. M., Mitchell, S. A., Meeneghan, M., Battaglini, C. L., … Wood, W. A. (2016). Evaluation of pedometry as a patient-centered outcome in patients undergoing hematopoietic cell transplant (HCT): A comparison of pedometry and patient reports of symptoms, health, and quality of life. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 25(3), 535–546. doi:10.1007/s11136-015-1179-0.CrossRef

Garcia, C. M., Mumby, P. B., Thilges, S., & Stiff, P. J. (2012). Comparison of early quality of life outcomes in autologous and allogeneic transplant patients. Bone Marrow Transplantation, 47(12), 1577–1582. doi:10.1038/bmt.2012.77.CrossRefPubMed

Prieto, J. M., Atala, J., Blanch, J., Carreras, E., Rovira, M., Cirera, E., & Gastó, C. (2005). Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation. Bone Marrow Transplantation, 35(3), 307–314. doi:10.1038/sj.bmt.1704788.CrossRefPubMed

Sherman, A. C., Simonton, S., Latif, U., Plante, T. G., & Anaissie, E. J. (2009). Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Biology of Blood and Marrow Transplantation, 15(1), 12–20. doi:10.1016/j.bbmt.2008.09.023.CrossRefPubMed

Andrykowski, M. A., Bishop, M. M., Hahn, E. A., Cella, D. F., Beaumont, J. L., Brady, M. J., … Wingard, J. R. (2005). Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. Journal of Clinical Oncology, 23(3), 599–608. doi:10.1200/JCO.2005.03.189.CrossRefPubMed

Bieri, S., Roosnek, E., Helg, C., Verholen, F., Robert, D., Chapuis, B., … Chalandon, Y. (2008). Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplantation, 42(12), 819–827. doi:10.1038/bmt.2008.253.CrossRefPubMed

Sun, C.-L., Kersey, J. H., Francisco, L., Armenian, S. H., Baker, K. S., Weisdorf, D. J., … Bhatia, S. (2013). Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: Report from the bone marrow transplantation survivor study. Biology of Blood and Marrow Transplantation, 19(7), 1073–1080. doi:10.1016/j.bbmt.2013.04.002.CrossRefPubMedPubMedCentral

10.

Anderson, K. O., Giralt, S. A., Mendoza, T. R., Brown, J. O., Neumann, J. L., Mobley, G. M., … Cleeland, C. S. (2007). Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplantation, 39(12), 759–766. doi:10.1038/sj.bmt.1705664.CrossRefPubMed

11.

Andersson, I., Ahlberg, K., Stockelberg, D., Brune, M., & Persson, L.-O. (2009). Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning. Cancer Nursing, 32(4), 325–334. doi:10.1097/NCC.0b013e31819b5c81.CrossRefPubMed

12.

Elliott, B. A., Renier, C. M., Haller, I. V., & Elliott, T. E. (2004). Health-related quality of life (HRQoL) in patients with cancer and other concurrent illnesses. Quality of Life Research, 13(2), 457–462. doi:10.1023/B:QURE.0000018476.11278.35.CrossRefPubMed

13.

Nelson, A. M., Coe, C. L., Juckett, M. B., Rumble, M. E., Rathouz, P. J., Hematti, P., & Costanzo, E. S. (2014). Sleep quality following hematopoietic stem cell transplantation: Longitudinal trajectories and biobehavioral correlates. Bone Marrow Transplantation, 49(11), 1405–1411. doi:10.1038/bmt.2014.179.CrossRefPubMedPubMedCentral

14.

Kenzik, K., Huang, I.-C., Rizzo, J. D., Shenkman, E., & Wingard, J. (2015). Relationships among symptoms, psychosocial factors, and health-related quality of life in hematopoietic stem cell transplant survivors. Supportive Care in Cancer, 23(3), 797–807. doi:10.1007/s00520-014-2420-z.CrossRefPubMed

15.

Bevans, M. F., Mitchell, S. A., & Marden, S. (2008). The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). Supportive Care in Cancer, 16(11), 1243–1254. doi:10.1007/s00520-008-0420-6.CrossRefPubMedPubMedCentral

16.

Lynch Kelly, D., Lyon, D. E., Ameringer, S. A., & Elswick, R. K. (2015). Symptoms, cytokines, and quality of life in patients diagnosed with chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Oncology Nursing Forum, 42(3), 265–275. doi:10.1188/15.ONF.265-275.CrossRefPubMed

17.

Schulz-Kindermann, F., Hennings, U., Ramm, G., Zander, A. R., & Hasenbring, M. (2002). The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT. Bone Marrow Transplantation, 29(4), 341–351. doi:10.1038/sj.bmt.1703385.CrossRefPubMed

18.

Wingard, J. R., Huang, I.-C., Sobocinski, K. A., Andrykowski, M. A., Cella, D., Rizzo, J. D., … Bishop, M. M. (2010). Factors associated with self-reported physical and mental health after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation, 16(12), 1682–1692. doi:10.1016/j.bbmt.2010.05.017.CrossRefPubMedPubMedCentral

19.

Hamilton, B. K., Law, A. D., Rybicki, L., Abounader, D., Dabney, J., Dean, R., … Majhail, N. S. (2015). Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients. Bone Marrow Transplantation, 50(9), 1235–1240. doi:10.1038/bmt.2015.122.CrossRefPubMed

20.

Pillay, B., Lee, S. J., Katona, L., Burney, S., & Avery, S. (2014). Psychosocial factors predicting survival after allogeneic stem cell transplant. Supportive Care in Cancer, 22(9), 2547–2555. doi:10.1007/s00520-014-2239-7.CrossRefPubMed

21.

Terrin, N., Rodday, A. M., & Parsons, S. K. (2015). Joint models for predicting transplant-related mortality from quality of life data. Quality of Life Research, 24(1), 31–39. doi:10.1007/s11136-013-0550-2.CrossRefPubMed

22.

Wong, F. L., Francisco, L., Togawa, K., Bosworth, A., Gonzales, M., Hanby, C., … Bhatia, S. (2010). Long-term recovery after hematopoietic cell transplantation: Predictors of quality-of-life concerns. Blood, 115(12), 2508–2519. doi:10.1182/blood-2009-06-225631.CrossRefPubMedPubMedCentral

23.

Tallman, B., Shaw, K., Schultz, J., & Altmaier, E. (2010). Well-being and posttraumatic growth in unrelated donor marrow transplant survivors: A nine-year longitudinal study. Rehabilitation Psychology, 55(2), 204–210. doi:10.1037/a0019541.CrossRefPubMed

24.

Morishita, S., Kaida, K., Yamauchi, S., Wakasugi, T., Yoshihara, S., Taniguchi, K., … Domen, K. (2013). Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation. Psycho-Oncology, 22(5), 1159–1166. doi:10.1002/pon.3128.CrossRefPubMed

25.

Wettergren, L., Langius, A., Björkholm, M., & Björvell, H. (1997). Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation–a prospective study. Bone Marrow Transplantation, 20(6), 497–502. doi:10.1038/sj.bmt.1700921.CrossRefPubMed

26.

Gielissen, M. F. M., Schattenberg, A. V. M., Verhagen, C. A. H. H. V. M., Rinkes, M. J., Bremmers, M. E. J., & Bleijenberg, G. (2007). Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplantation, 39(10), 595–603. doi:10.1038/sj.bmt.1705624.CrossRefPubMed

27.

Prieto, J. M., Blanch, J., Atala, J., Carreras, E., Rovira, M., Cirera, E., & Gastó, C. (2006). Clinical factors associated with fatigue in haematologic cancer patients receiving stem-cell transplantation. European Journal of Cancer, 42(12), 1749–1755. doi:10.1016/j.ejca.2005.10.005.CrossRefPubMed

28.

Braamse, A. M. J., Gerrits, M. M. J. G., van Meijel, B., Visser, O., van Oppen, P., Boenink, A. D., … Dekker, J. (2012). Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies. Bone Marrow Transplantation, 47(6), 757–769. doi:10.1038/bmt.2011.130.CrossRefPubMed

29.

Bevans, M. F., Mitchell, S. A., Barrett, J. A., Bishop, M. R., Childs, R., Fowler, D., … Yang, L. (2014). Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors. Biology of Blood and Marrow Transplantation, 20(3), 387–395. doi:10.1016/j.bbmt.2013.12.001.CrossRefPubMed

30.

Revenson, T. A., & DeLongis, A. (2011). Couples coping with chronic illness. In S. Folkman (Ed.), The oxford handbook of stress, health, and coping (pp. 101–123). Oxford: Oxford University Press.

31.

Bolger, N., & Laurenceau, J.-P. (2013). Intensive longitudinal methods: An introduction to diary and experience sampling research. New York: Guilford Press.

32.

Sprangers, M. A., Cull, A., Groenvold, M., Bjordal, K., Blazeby, J., & Aaronson, N. K. (1998). The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: An update and overview. EORTC Quality of Life Study Group. Quality of Life Research, 7(4), 291–300.CrossRefPubMed

33.

Larsen, R. J., & Kasimatis, M. (1991). Day-to-day physical symptoms: Individual differences in the occurrence, duration, and emotional concomitants of minor daily illnesses. Journal of Personality, 59(3), 387–423.CrossRefPubMed

34.

Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981). Reporting results of cancer treatment. Cancer, 47(1), 207–214.CrossRefPubMed

35.

Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. doi:10.1177/014662167700100306.CrossRef

36.

Bolger, N., Davis, A., & Rafaeli, E. (2003). Diary methods: Capturing life as it is lived. Annual Review of Psychology, 54, 579–616. doi:10.1146/annurev.psych.54.101601.145030.CrossRefPubMed

37.

Hox, J. J., Moerbeek, M., & van de Schoot, R. (2010). Multilevel analysis: Techniques and applications (2 edn.). New York: Routledge.

38.

Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39(2), 175–191. doi:10.3758/BF03193146.CrossRefPubMed

39.

Kwok, O.-M., Underhill, A. T., Berry, J. W., Luo, W., Elliott, T. R., & Yoon, M. (2008). Analyzing longitudinal data with multilevel models: An example with individuals living with lower extremity intra-articular fractures. Rehabilitation Psychology, 53(3), 370–386. doi:10.1037/a0012765.CrossRefPubMedPubMedCentral

40.

Katon, W. J. (2003). Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biological Psychiatry, 54(3), 216–226.CrossRefPubMed

41.

Herbert, T. B., & Cohen, S. (1993). Depression and immunity: A meta-analytic review. Psychological Bulletin, 113(3), 472–486.CrossRefPubMed

42.

Bacigalupo, A., Ballen, K., Rizzo, D., Giralt, S., Lazarus, H., Ho, V., … Horowitz, M. (2009). Defining the intensity of conditioning regimens: working definitions. Biology of Blood and Marrow Transplantation, 15(12), 1628–1633. doi:10.1016/j.bbmt.2009.07.004.CrossRefPubMedPubMedCentral

43.

Laursen, B. P., & Hoff, E. (2006). Person-centered and variable-centered approaches to longitudinal data. Merrill-Palmer Quarterly, 52(3), 377–389. doi:10.1353/mpq.2006.0029.CrossRef

Title: Everyday life following hematopoietic stem cell transplantation: decline in physical symptoms within the first month and change-related predictors
Authors: Aleksandra Kroemeke
Małgorzata Sobczyk-Kruszelnicka
Zuzanna Kwissa-Gajewska
Publication date: 01-01-2018
Publisher: Springer International Publishing
Published in: Quality of Life Research / Issue 1/2018
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-017-1705-3

At a glance: The STEP trials

Springer Medicine

Everyday life following hematopoietic stem cell transplantation: decline in physical symptoms within the first month and change-related predictors

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Effects of risk factors for and components of metabolic syndrome on the quality of life of patients with systemic lupus erythematosus: a structural equation modeling approach

Prevalence of patient-reported gastrointestinal symptoms and agreement with clinician toxicity assessments in radiation therapy for anal cancer

Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al

How is weight stigma related to children’s health-related quality of life? A model comparison approach

The relationship of five boarding school experiences and physical health status among Northern Plains Tribes

Development of a care guidance index based on what matters to patients